Newronika Announces CE Mark Approval for AlphaDBS™ System for Parkinson’s Disease
Newronika, a spin-off of the world-class neurological research center Policlinico of Milan and University of Milan, announced today it received CE Mark approval for its AlphaDBS System.
For more information: